Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L10 pseudogene 5 (RPL10P5) is a processed pseudogene of the ribosomal protein L10 gene. It is classified as a pseudogene, meaning it is a non-functional segment of DNA resulting from the duplication or retrotransposition of the functional RPL10 gene, and it does not encode an active protein product. There are no documented biological functions, disease associations, drug interactions, or mechanisms of action related to RPL10P5 because, as a pseudogene, it is not translated into a functional protein and is not regarded as a therapeutic target. RPL10P5 is often listed in genetic and genomic databases, but it does not have a known physiological or pathological role in humans beyond being a remnant of genomic evolution. The closely related functional gene, ribosomal protein L10 (RPL10), encodes a component of the 60S ribosomal subunit, but RPL10P5 itself is non-functional. Therefore, any target- or drug-related information applies to RPL10, not RPL10P5.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L10 pseudogene 5 (RPL10P5).